Invivyd (IVVD) Capital Expenditures (2021 - 2025)
Invivyd (IVVD) reported Capital Expenditures of $11000.0 for Q2 2025, down 92.36% quarter-over-quarter from $144000.0 in Q1 2025.
Invivyd (IVVD) Capital Expenditures (2021 - 2025) Analysis & Trends
Invivyd has reported Capital Expenditures for 5 years, with the latest figure at $11000.0 in Q2 2025.
- For the quarter ending Q2 2025, Capital Expenditures changed N/A year-over-year to $11000.0; the trailing twelve-month figure through Dec 2025 stood at $155000.0 (up 10.71% YoY), and the FY2025 full-year result was $155000.0, up 10.71% from the prior year.
- Capital Expenditures for Q2 2025 stood at $11000.0, down from $144000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $1.2 million in Q4 2022, with the low at -$9000.0 in Q2 2023.
- Historically, Capital Expenditures has averaged $245363.6 across 5 years, with a median of $84000.0 in 2021.
- Annual changes were most pronounced in 2022 — Capital Expenditures surged 1341.67% — and 2023, when it sank 152.94%.
- Invivyd's Capital Expenditures stood at $84000.0 in 2021, then surged by 1341.67% to $1.2 million in 2022, then tumbled by 100.74% to -$9000.0 in 2023, then surged by 44.44% to -$5000.0 in 2024, then soared by 320.0% to $11000.0 in 2025.
- The last three Capital Expenditures figures came in at $11000.0 (Q2 2025), $144000.0 (Q1 2025), and -$5000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 144,000.00 |
| Mar 31, 2025 | 144,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Jun 30, 2023 | -9,000.00 |
| Jun 30, 2023 | -9,000.00 |
| Mar 31, 2023 | 624,000.00 |
| Mar 31, 2023 | 624,000.00 |
| Dec 31, 2022 | 1.21 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 477,000.00 |
| Sep 30, 2022 | 477,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 17,000.00 |